Could vitamin d help heart surgery patients recover better?
NCT ID NCT04986033
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 135 adults having off-pump coronary artery bypass surgery to see if vitamin D levels affect hemoglobin (a protein in red blood cells) recovery after surgery. Researchers measured vitamin D and a hormone called hepcidin, which controls iron use. The goal was to understand why many patients develop anemia after heart surgery and whether vitamin D plays a role.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors understand why some patients develop anemia after heart surgery and point to vitamin D as a potential way to improve recovery.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks for links between vitamin D and hemoglobin, so it won't prove that giving vitamin D helps. Results may not apply to all heart surgery patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
135 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who consented to study enrollment among patients scheduled for off-pump coronary artery bypass graft
- Ages
-
20 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1\. Patients over 20 years of age undergoing off-pump coronary artery bypass graft Exclusion Criteria: 1. Emergency operation 2. Minimal invasive coronary artery bypass graft 3. Cooperative operation with other surgery 4. Patients who need a mechanical ventricular assist device 5. Patients with chronic kidney disease (eGFR \< 30) 6. Patients who have a end stage renal disease and need a hemodialysis 7. Patients with a low hemoglobin (Hb \< 10) before surgery 8. Patients who have a some disease(leukemia, myeloma, aplastic anemia, sickle cell anemia, etc) affecting hematopoiesis 9. Patients with a liver cirrhosis 10. Patients who receive vit. D, iron supplements, erythropoietin within 6 months 11. Patients who cannot understand the informed consent (eg. Foreigner, patients with cognitive dysfunction, etc) 12. Patients who disagree this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, Cardiovascular Hospital, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- New heart scan aims to spot hidden plaque before it strikes
- Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?